Legislative record
119-HR10150FEDERALIn Committee
To amend the Federal Food, Drug, and Cosmetic Act to provide a period of market exclusivity for botanical drugs, and for other purposes.
Latest action: Referred to the House Committee on Energy and Commerce.
Voted 8/27/2026View source